Work

IMMU-39. T cell receptor diversity is a predictor of therapy response in patients with gliomas treated with Delta-24-RGD

Year: 2025

Type: conference-abstract

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaf201.0837

Authors: Dong Ho Shin, Andrew Gillard, Hong Jiang, Andres Lopez-Rivas, Akhila Parthasarathy, Xuejun Fan, Marta Alonso, Jiasen He, Duy Nguyen, Christopher Alvarez-Breckenridge, Chibawanye Ene, Frederick Lang, Candelaria Gomez-Manzano, Juan Fueyo

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston, Clinica Universidad de Navarra

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416140449

Cites:

Cited by:

Related to: